Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.
Heart icon (animated) heart icon (static)
Our Initiatives
Explore more Johnson & Johnson sites:
A graphic of the flag of Australia alt
A graphic of the flag of Argentina alt
A graphic of the flag of Brazil alt
A graphic of the national flag of Canada alt
A graphic of the flag of Chile alt
A graphic of the national flag of the People's Republic of China alt
A graphic of the national flag of Colombia alt
A graphic of the national flag of Ecuador alt
A graphic of the flag of Germany alt
A graphic of the national flag of India alt
A graphic of the national flag of Japan alt
A graphic of the flag of Mexico alt
A graphic of the flag of Paraguay alt
A graphic of the flag of Peru alt
A graphic of the flag of Russia alt
Switzerland
A graphic of the flag of Switzerland alt
A graphic of the national flag of Uruguay alt
A graphic of the flag of Venezuela alt
Share

Advancing Equitable Access to Care for Everyone, Everywhere

Advancing Access and Innovation for Health Equity
Advancing Access and Innovation for Health Equity

or more than a decade, Johnson & Johnson has been recognized by the independent Access to Medicine Foundation as one of the top three companies working to advance access to medicines and technologies in low- and middle-income countries.

This consistent recognition of our leadership is the result of a longstanding, deliberate and focused strategy aimed at solving some of the most difficult global health challenges and advancing equitable access to care for everyone, everywhere.

Learn more about how we never stop working to ensure good health for the people we serve.

More Than a Decade of Leadership in Access to Innovation

Our relentless focus on equitable access to healthcare is reflected in its consistent high ranking on the Access to Medicine Index (ATMI), a biennial report card that grades the world’s largest pharmaceutical companies on their efforts to distribute medications, vaccines and diagnostics to low- and middle-income countries. For ten years, Johnson & Johnson has placed in the top three on the list and in the 2021 report, we have once again earned a #3 spot overall, and advanced two places in the research and development category to take the #2 spot. Our consistent performance in the top three position underscores the our deep history of ensuring people in underserved communities receive the treatments they need.

expand

Our Commitment to Advance Access to Medicines and Technologies

Spotlight on Our Breakthrough Access Programs

Champions for Access

Paul Stoffels
Quote icon (top)

We are committed, more than ever before, to advance a safer, healthier and more equitable world where everyone can thrive.

Quote icon (bottom)
Quote icon (top)

Our Global Public Health unit works to expand equitable access to our medicines and technologies for the world's most underserved people.

Quote icon (bottom)
Quote icon (top)

Our research and development pipeline focuses heavily on diseases that primarily impact underserved populations—and we integrate access planning into everything we do.

Quote icon (bottom)
Quote icon (top)

Our 25 years of experience in addressing global health challenges is informing our response to COVID-19, a global crisis that is laying bare the global inequities in accessing care.

Quote icon (bottom)
Quote icon (top)

We're committed to expanding equitable access to care in Africa by strengthening health systems, supporting frontline health workers and investing in local partnerships.

Quote icon (bottom)
This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
Close cookie banner icon
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue